• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1991 Fiscal Year Final Research Report Summary

Portal Hypertension in Liver Cirrhosis and Drug Therapy

Research Project

Project/Area Number 01570411
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Gastroenterology
Research InstitutionThe Jikei University School of Medicine

Principal Investigator

OHNISHI Akihiro  The Jikei University School of Medicine, Lecturer, 医学部, 講師 (00194225)

Co-Investigator(Kenkyū-buntansha) OSAKA Kazuhiro  The Jikei University School of Medicine, Assistant, 医学部, 助手
TSUCHIYA Takumi  The Jikei University School of Medicine, Assistant, 医学部, 助手 (80207406)
HARADA Makoto  The Jikei University School of Medicine, Assistant, 医学部, 助手
MURAKAMI Shigeto  The Jikei University School of Medicine, Assistant, 医学部, 助手 (20219893)
Project Period (FY) 1989 – 1991
KeywordsLiver cirrhosis / ascites / noradrenaline / prostacycline / thromboxane A_2 / natriuresis / portal hypertension / angiotensin II
Research Abstract

Because renin and angiotensin levels are increased in patients with liver eirrhosis, it could be logical to investigate the effects of angiotensin converting enzyme(ACE)inhibitors on portal hemodynamics. Additionaly, given the evidences that some prostaglandin(PG)may be involved in regulation of hepatic resistance and perhaps even in maintenance of the hyperdynamic state, more studies of PG effects on hepatic and portal hemodynamics are warranted.
Because of few studies investigated the above these issues, we started to investigate the renin, angiotensin II, catecholamines, and prostanoids levels both in systemic (S) and portal (P) blood circulations from animal models and the patients with liver cirrhosis. In two experimetal animal models (the rats with CCl_4-induced liver cirrhosis (LC rat) and the rats with portal hypertension induced by 2 weeks partial ligation (PH rat)) and control (C) rats, we measured the stable PG metabolites 6-keto-prostagiandin F_<1alpha> (6KPG), from PGI_2, a … More nd thromboxane B_2 (TXB_2), from TXA_2 by radioimmunoassay employing rabbit-antibody. The 6KPG concentrations in tge S and P circulations were approximately 2 and 5 times higher (p<0.05) in LC rats(S, 2008 <plus-minus>549 pg/ml ; P, 4802<plus-minus>654 pg/ml) than in C rats (S, 1116<plus-minus>186 pg/ml ; P 983<plus-minus>177 pg/ml (mean<plus-minus>SE)). The tissue 6KPG of the portal vein was significantly higher in LC and PH rats than in C rats (255<plus-minus>36, 415<plus-minus>43, 142<plus-minus>23 pg/mgWW, respectively). The S and P TXB_2 concentrations were higher in LC rats(S, 3059<plus-minus>1309 pg/ml ; P, 2315<plus-minus>633 pg/ml) than in PH-rats (S, 1243(]SY.+-. (]178 pg/ml ; P, not obtained) and C rats (S, 343(]SY.+-.[)63 pg/ml ; P, 417(]SY.+-.[)65 pg/ml). The tissue TXB_2 levels did not differ between the model rats and the C rats. In the clinical study, we collected the PG's blood samples from 11 cirrhotic patients. 6KPG and TXB_2 levels in the P circulation were significantly (p<0.01) higher than (10 and 14 times) those in the S circulation : 57(]SY.+-.[)31 and 484(]SY.+-.[)192 pg/ml in P, 4(]SY.+-.[)1 and 50(]SY.+-.[)8 pg/ml in S, respectively. These results indicated that production of PG, particularly PGI_2, is stimulated in the portal circulation in liver cirrhosis and could be involved in the elevation of intraportal pressure.
In the second step, we investigated the renal effects of an ACE inhibitor, enalapril in ten patients with liver cirrhosis. Enalapril was administered orally at the dose of 10 mg for eight days. As a result we observed clinically favorable renal effects of enalapril, that is, it increased creatinine clearance markedly and produced considerable natriuresis. This results suggested that enalapril, a ACE inhibitor, may be one of tools for the treatment of cirrhotic condition complicated with peripheral edema and ascites. Less

  • Research Products

    (11 results)

All Other

All Publications (11 results)

  • [Publications] Ohnishi,A.: "Hormonal and renal responses to two different angiotensin converting enzyme inhibitors in cirrhosis." Hepatology. 8. 1384 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohnishi,A.: "Kinetics and dynamics of enalapril in patients with liver cirrhosis." Clinical Pharmacology & Therapeutics. 45. 657-665 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohnishi,A.: "Intrapatient comparison of acute hemodynamic,hormonal and natriuretic responses to captopril versus enalapril in liver cirrhosis." Clinical Pharmacology & Therapeutics. 48. 67-75 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大野 俊幸: "肝疾患とアンギオテンシン変換酵素(ACE)活性の変動" 肝臓. 32. 266-273 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohnishi,A.: "Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation,catecholamine concentration and platelet aggregation in humans." Clinical Pharmacology & Therapeutics. 51. (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohnishi,A.: "Renal and hormonal responses to a repeated treatment with enalapril in nonazotemic liver cirrhosis with ascites." Hepatology. 15. (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Akihiro Ohnishi: "Hormonal and renal responses to two different angiotensin converting enzyme inhibitors in cirrhosis" Hepatology. 8. 1384 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akihiro Ohnishi: "Kinetics and dynamics of enalapril in patients with liver cirrhosis" Clin. Pharmacol. Ther.45. 657-665 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akihiro Ohnishi: "Intrapatient comparison of acute hemodynamic, hormonal and natriuretic responses to captopril versus enalapril in liver cirrhosis" Clin. Pharmacol. Ther.48. 67-75 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akihiro Ohnishi: "Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration and platelet aggregation in humans" Clin. Pharmacol. Ther.51. (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akihiro Ohnishi: "Renal and hormonal responses to a repeated treatment with enalapril in nonazotemic liver cirrhosis with ascites" Hepatology. 15. (1992)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi